Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients

Patients with advanced Parkinson's disease (PD) experience body weight loss and reductions in the most common cardiovascular risk factors. At present, the pathogenetic mechanisms involved have not been elucidated. Increased serum concentrations of adiponectin, which possesses antiatherogenic an...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Cassani, Erica, Cancello, Raffaella, Cavanna, Ferruccio, Maestrini, Sabrina, Di Blasio, Anna Maria, Liuzzi, Antonio, Pezzoli, Gianni, Barichella, Michela
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE-Hindawi Access to Research 2011
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3135047/
https://ncbi.nlm.nih.gov/pubmed/21766000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2011/624764
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky